Novo Nordisk A/S

(NVO) Trade

By |

Profile

With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, as well as oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 20% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Contact Information

Website: www.novonordisk.com
Email: phak@novonordisk.com
Main Phone: +45 44448888
Address: Novo Alle
City / Town: Bagsvaerd
Country: DNK
Postal Code: 2880

Issuer Information

Exchange: NYE
CEO: Lars Fruergaard Jorgensen
Employees: 42154
NAICS: Pharmaceutical P

Equities News

View More

Profile

With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, as well as oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 20% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Contact Information

Website: www.novonordisk.com
Email: phak@novonordisk.com
Main Phone: +45 44448888
Address: Novo Alle
City / Town: Bagsvaerd
Country: DNK
Postal Code: 2880

Issuer Information

Exchange: NYE
CEO: Lars Fruergaard Jorgensen
Employees: 42154
NAICS: Pharmaceutical P

Equities News

View More
$ 53.29 $ 0.69 (1.31%)
Last Price 53.29 Change $ 0.69 Change % 1.31 Tick N/A
Bid 53.55 Bid Size 500.00 Ask 53.61 Ask Size 400.00
Open 53.40 High 53.80 Low 53.13 Prev Close 52.60
Last Trade Volume 1.2 mi 52 Wk Hi 53.80 52 Wk Low 41.59
Market Cap 126 bi Ex-Div Date Div Rate 0.90 Yield 1.6870
Shares 2,364,853,006.00 EPS (TTM) 2.42 PE Ratio 21.10 Exchange NYSE
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 60.4 60.4 60.4 60.4
Low Target Price Estimate 60.4 60.4 60.4 60.4
Mean Target Price Estimate 60.4 60.4 60.4 60.4
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 05/29/18 05/29/18 05/03/18 05/29/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 1 1 1 1
Moderate Buy 1 1 1 1
Hold 2 2 2 3
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.13 2.13 2.13 2.3